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ABSTRACT 
The purpose of this study was to investigate whether 
obese rats with a strong anorectic response to growth 
hormone also showed signs of increased hepatic ke-
togenesis as reflected in circulating β-hydroxybu- 
tyrate levels. Rats with diet-induced obesity were al-
located to one of two groups, receiving either vehicle 
(n = 7) or 4 mg/kg/d of growth hormone (n = 13) for 4 
days. This latter group was later split into a group of 
responders (n = 8) showing a cumulated reduction of 
food intake of more than 4 g from base line during 
the last two days of administrations and a group of 
non-responders (n = 5). The cumulated reduction of 
food intake from baseline among the responders was 
10.8 ± 1.5 g. The corresponding marginal reductions 
in the non-responder and vehicle groups were 0.5 ± 
3.4 g and 0.5 ± 3.7 g, respectively. Growth hormone 
administration generally increased serum levels of β- 
hydroxybutyrate and free fatty acids, compared with 
vehicle, whereas triglycerides were decreased. Among 
the responders this effect was statistically significant 
in all instances whereas the same trend was weaker 
among non-responders. The main finding of the pre- 
sent study was that the serum β-hydroxybutyrate lev- 
els of 0.76 ± 0.11 mmol/l among responders was three 
times higher than non-responders (p < 0.01). In con- 
clusion, the present study suggests that increased he- 
patic ketogenesis is an important component in the 
mechanism by which growth hormone inhibits food 
intake in rats with an obese phenotype. The precise 
molecular mechanisms, however, remain to be eluci- 
dated. 
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1. INTRODUCTION 
Growth hormone (GH) is a powerful stimulator of lipid 
oxidation [1] and energy expenditure [2]. We have pre-
viously shown that the excess of body fat of obese rats is 
broken down within just 3 weeks during pharmacologic 
exposure to GH and that inhibition of food intake is seen 
in the first phase of this period [3,4]. In our most recent 
study, the decrease in food intake was associated with 
decreased hypothalamic galanin [1]. Further investiga-
tions of the physiological events associated with the an-
orectic effect of GH are principally interesting and moti-
vated. They may provide additional evidence for a link 
between increased rates of lipid oxidation and inhibition 
of food intake, and lead to discovery of effective targets 
for the treatment of obesity. Several authors have sug- 
gested that the liver plays a crucial role in this associa- 
tion [5], and that metabolic signals from this organ may 
affect higher brain centers so that food intake is reduced. 
Hepatic  β-oxidation of fatty acids generates β-hy- 
droxybutyrate which is released into the circulation in 
proportion to the rate of lipid oxidation. We have noticed 
that the plasma concentration of β-hydroxybutyrate shows 
a relatively high variation during GH administration and 
the same is true for food intake. Work with this study, we 
were interested to investigate whether the group of obese 
rats with a strong anorectic response to GH also exhib- 
ited high levels of circulating β-hydroxybutyrate re- 
sponse as a marker of increased hepatic fatty acid oxida- 
tion and ketogenesis.  *Corresponding author. B. Xu et al. / Open Journal of Molecular and Integrative Physiology 3 (2013) 80-82 
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2. MATERIALS AND METHODS 
2.1. Experimental Procedures 
The experiments were performed in accordance with the 
Declaration of Helsinki and were ethically approved by 
the Regional Ethical Committee for Animal Trials (Upp- 
sala, Sweden). Diet induced obesity (DIO) was estab- 
lished in 12 month old Female Wistar rats (Scanbur AB, 
Sollentuna, Sweden) by providing free access to high fat 
diet for three months as previously described [3]. Water 
was freely available at all times. The rats were subjected 
to a 12/12 h light/dark regime, and the room temperature 
was held between 23˚C and 25˚C. The DIO rats were 
later randomly allocated to one of two groups, receiving 
either vehicle (n = 7) or GH (n = 13).This latter group 
was later divided in two groups, responders (n = 8) and 
non-responders (n = 5). The responders showed a cumu- 
lated reduction of food intake, from baseline, of more 
than 4 g during the last two days of the experiment (See 
Figure 1), whereas the response in non-responders (n = 5) 
was less than this level. The food intake during the day 
before first injection served as baseline. Administrations 
of recombinant human GH (Novo Nordisk AS, Bags 
vaerd, Denmark) were sustained for 4 days at a dose of 2   
 
 
Figure 1. (a) Effects of GH on food intake in old obese rats 
responding with a decreased food intake (●), compared with 
those showing a weak or no response (▼) and with those re-
ceiving vehicle alone (□); (b) Cumulated reduction of food 
intake from baseline over the 4 day study period among in the 
same groups as in section A. The results are expressed as means 
(n = 5 - 8) together with SEM. 
mg/kg given twice daily at 08:00 h and 18:00 h. There- 
after, animals were killed by decapitation. Decapitation 
was carried out between 10:00 - 12:00 hours on day 4, 
and blood serum for analyses of clinical chemistry was 
prepared by allowing blood to clot before being centri-
fuged at 5000 rpm during 20 minutes. Serum was stored 
in −80˚C before being analyzed. Biochemical analyses of 
serum were performed according to standard protocoles 
at the Department of Clinical Chemistry (Veterinary 
Faculty, SLU, Uppsala, Sweden). 
2.2. Statistics 
The differences between the groups were evaluated by 
ANOVA, followed by Bonferroni’s post hoc test for mul-
tiple comparisons or Kruskal Wallis non parametric test 
followed by Dunn’s multiple comparison test. The data 
analysis were executed in the GraphPad Prism 5.02 pro-
gram (GraphPad Software, Inc., La Jolla, CA, USA). 
Mean values were considered significantly different for p 
values less than 0.05 (p < 0.05), and data are presented as 
means together with standard error (SEM). 
3. RESULTS 
3.1. Effects of GH on Food Intake 
Over the 4 day study period, the cumulated reduction of 
food intake from baseline among the responders was 
10.8 ± 1.5 g (Figures 1(a) and (b)). The corresponding 
marginal reductions were 0.5 ± 3.4 g and 0.5 ± 3.7 g for 
the non-responder and vehicle groups, respectively. Since 
the rats in the responder and non-responder groups were 
purposely selected, no statistical test for difference in 
food intake was performed on these groups. 
3.2. Effects of GH on Plasma Lipid Metabolites   
in Obese Animals 
GH administration generally increased circulating levels 
of  β-hydroxybutyrate (BHB), and non-esterified fatty 
acids (NEFA) whereas triacylglycerol was decreased 
(Table 1). Among the responders this effect was statisti-
cally significant in all instances whereas the same trend 
was weaker and not always statistically significant among 
non-responders. However, the main finding in this work 
was that the increase in β-hydroxybutyrate among re- 
sponders was not only significantly different from vehi-
cle rats but also strikingly different (p < 0.01) compared 
with the non-responders (Table 1). 
4. DISCUSSION 
The data generated in the present work shows that ani- 
mals with a strong anorectic response to GH also have 
significantly higher levels of -hydroxybutyrate than B. Xu et al. / Open Journal of Molecular and Integrative Physiology 3 (2013) 80-82 
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Table 1. Serum lipid metabolites in 12-month-old obese rats 
responding to GH (4 mg/kg/d) with a decreased food intake, 
compared with non-responders and with those receiving vehicle 
alone. Results are expressed as means (SEM). 
   β-hydroxybutyrate Triglycerides Free Fatty acids
Groups n  mmol/l  mmol/l  mmol/l 
Vehicle 7 0.10
a (0.01)  4.2
a (0.90)  0.46
a (0.04) 
GH 
non-responders  5 0.24
b (0.05)  2.0
ab (0.13)  0.50
ab (0.05)
GH responders  8  0.76
c* (0.11)  1.7
b (0.18)  0.61
b (0.03) 
a,b,cValues within columns not sharing a common letter differ significantly (p 
< 0.05); 
*p < 0.01. 
 
have animals showing a weaker response. This novel 
finding is consistent with the previously proposed idea 
that there is a close connection between increased peri- 
pheral fatty acid oxidation and reduced food intake [6] 
since -hydroxybutyrate is a well-established metabolic 
marker of hepatic oxidation of fatty acids. Thus, our data 
show that in rats where GH produces a strong stimulation 
of hepatic lipid oxidation and ketogenesis, food intake is 
also significantly reduced, and that the opposite is true in 
animals with a more modest stimulation of hepatic lipid 
oxidation. This does not, however, automatically mean 
that it is -hydroxybutyrate that in itself constitutes the 
key signal from the periphery acting on the brain to de- 
crease food intake. In fact, previous trials to demonstrate 
a direct effect of -hydroxybutyrate have generated in- 
consistent results [7,8] whereas inhibition of fatty acid 
oxidation has shown more robust results, namely sti- 
mulation of food intake [9]. For these reasons it seems 
reasonable to conclude that circulating -hydroxybu- 
tyrate may not be the key message from fatty acid oxida-
tion that influences food intake [10]. This conclusion is 
supported by a recent uncontrolled pilot study from our 
lab (data not shown) where obese rats received a massive 
per oral doses of 30 mmol/kg/day of D-L--hydroxybu-
tyrate for 4 days. No evidence of reduced food intake 
could be observed in that study; instead food intake was 
unchanged or slightly elevated throughout the study, 
compared with baseline values. There are thus strong 
reasons to believe that it is some unknown factor in the 
process of hepatic ketogenesis that constitutes the link 
between increase lipid oxidation and suppression of ap-
petite. 
In conclusion, the present study suggests that in- 
creased hepatic fatty acid oxidation and associated keto- 
genesis is an important component in the mechanism by 
which GH inhibits food intake in rats with an obese 
phenotype. The precise molecular mechanisms, however, 
remain to be elucidated. 
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